$8.20
0.08[0.99%]
At close: Apr 29
$8.20
0[0.00%]
PreMarket: 4:00AM EDT
Recursion Pharmaceuticals
(NASDAQ:RXRX)Recursion Pharmaceuticals Stock (NASDAQ:RXRX), Insider Trading Activity
Recursion Pharmaceuticals: Insider buying and selling updated today.
Shares Outstanding
237.522M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2024 | Blake Borgeson | DIRECTOR | -11.447K | $7.66 | -$87.73K | SELL | -0.16% | 7.229861M | Apr 16 | View |
| Apr 18, 2024 | Michael Secora | CHIEF FINANCIAL OFFICER | 26.876K | $4.92 | -$200.51K | SELL-OPTIONS | 2.23% | 1.231055M | Apr 16 - Apr 17 | View |
| Apr 05, 2024 | Christopher Gibson | CHIEF EXECUTIVE OFFICER | -105K | $8.93 | -$1.16M | SELL | -100.00% | 0 | Apr 03 - Apr 04 | View |
| Apr 03, 2024 | Blake Borgeson | DIRECTOR | -11.447K | $8.82 | -$100.94K | SELL | -0.16% | 7.241308M | Apr 02 | View |
| Apr 01, 2024 | Christopher Gibson | CHIEF EXECUTIVE OFFICER | -65K | $10.10 | -$656.50K | SELL | -100.00% | 0 | Mar 28 | View |
| Mar 25, 2024 | Tina Marriott | PRESIDENT AND COO | 0 | $5.90 | -$77.50K | SELL-OPTIONS | 0.00% | 639.982K | Mar 21 | View |
| Mar 21, 2024 | Blake Borgeson | DIRECTOR | -20.054K | $10.79 | -$216.42K | SELL | -0.28% | 7.252755M | Mar 19 | View |
| Mar 14, 2024 | Michael Secora | CHIEF FINANCIAL OFFICER | 25K | $6.48 | -$370.69K | SELL-OPTIONS | 2.12% | 1.204179M | Mar 12 - Mar 13 | View |
| Mar 08, 2024 | Christopher Gibson | CHIEF EXECUTIVE OFFICER | 3.605K | $8.08 | -$543.12K | SELL-OPTIONS | ∞ | 0 | Mar 06 | View |
| Mar 07, 2024 | Blake Borgeson | DIRECTOR | -20.054K | $12.06 | -$241.81K | SELL | -0.27% | 7.272809M | Mar 05 | View |
| Feb 23, 2024 | Tina Marriott | PRESIDENT AND COO | 0 | $7.98 | -$110.68K | SELL-OPTIONS | 0.00% | 639.982K | Feb 22 | View |
| Feb 21, 2024 | Blake Borgeson | DIRECTOR | -20.054K | $12.32 | -$247.12K | SELL | -0.27% | 7.292863M | Feb 20 | View |
| Feb 15, 2024 | Michael Secora | CHIEF FINANCIAL OFFICER | 25K | $6.19 | -$341.48K | SELL-OPTIONS | 2.15% | 1.186351M | Feb 13 - Feb 14 | View |
| Feb 09, 2024 | Christopher Gibson | CHIEF EXECUTIVE OFFICER | -17.022K | $5.85 | -$367.48K | SELL | -2.15% | 774.703K | Feb 07 | View |
| Feb 08, 2024 | Blake Borgeson | DIRECTOR | -11.447K | $9.30 | -$106.49K | SELL | -0.16% | 7.312917M | Feb 06 | View |
| Jan 29, 2024 | Marriott Tina Larson | PRESIDENT AND COO | 0 | $5.70 | -$74.28K | SELL-OPTIONS | 0.00% | 414.548K | Jan 25 | View |
| Jan 25, 2024 | Blake Borgeson | DIRECTOR | -20.054K | $10.58 | -$212.08K | SELL | -0.27% | 7.324364M | Jan 23 | View |
| Jan 18, 2024 | Shafique Virani | CHIEF BUSINESS OFFICER | 0 | $6.58 | -$156.78K | SELL-OPTIONS | 0.00% | 136.748K | Jan 16 | View |
| Jan 18, 2024 | Michael Secora | CHIEF FINANCIAL OFFICER | 25K | $6.29 | -$351.01K | SELL-OPTIONS | 2.62% | 981.014K | Jan 16 - Jan 17 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.